Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bladder tumor markers

Edward M Messing

    The Journal of Urology
    |March 7, 2006
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A risk-adapted approach to reTURBT in high-grade T1 NMIBC.

    Bladder cancer (Amsterdam, Netherlands)·2026
    Same author

    Circulating tumor DNA-guided adjuvant immunotherapy in muscle-invasive bladder cancer.

    Bladder cancer (Amsterdam, Netherlands)·2026
    Same author

    Neoadjuvant chemotherapy for high-risk upper tract urothelial cancer.

    Bladder cancer (Amsterdam, Netherlands)·2026
    Same author

    Can urinary tumor DNA be used to assess the risk of recurrence in patients with non-muscle invasive bladder cancer?

    Bladder cancer (Amsterdam, Netherlands)·2025
    Same author

    Excluding PLND in favourable intermediate-risk prostate cancer: a PSMA-PET-directed perspective.

    Nature reviews. Urology·2025
    Same author

    When a 'routine' TURBT is not routine: Lessons from SEER-medicare.

    Bladder cancer (Amsterdam, Netherlands)·2025
    Same journal

    Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

    The Journal of urology·2026
    Same journal

    Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

    The Journal of urology·2026
    Same journal

    The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

    The Journal of urology·2026
    Same journal

    Let's Shift the Focus from Death to Life after Fournier's Gangrene.

    The Journal of urology·2026
    Same journal

    Endourology and Nephrolithiasis.

    The Journal of urology·2026
    Same journal

    With great cost comes great responsibility: who will own the rising costs of bladder cancer care?

    The Journal of urology·2026
    See all related articles